Table 2 IC50 (µg/ml) and SI values of all tested NPs samples against human cancer cell lines.
Sample | Caco-2 | HepG-2 | MCF-7 | PC-3 | ||||
|---|---|---|---|---|---|---|---|---|
IC50 | SI | IC50 | SI | IC50 | SI | IC50 | SI | |
Free NPs | 1989.8 ± 13 | 0.22 ± 0.004 | 432.5 ± 9.5 | 3.18 ± 0.89 | 925.2 ± 10.8 | 0.47 ± 0.007 | 736.9 ± 19.6 | 1.87 ± 0.061 |
LPO | 2029.4 ± 25 | 0.41 ± 0.009 | 873.9 ± 7.4 | 0.95 ± 0.03 | 1926.9 ± 17 | 0.43 ± 0.018 | 1154.3 ± 12 | 0.72 ± 0.02 |
LPO-loaded NPs | 813.1 ± 60.3 | 3.15 ± 0.01 | 503.2 ± 20.2 | 5.1 ± 0.02 | 339.7 ± 4.5 | 7.5 ± 1.6 | 776.8 ± 7.9 | 3.29 ± 0.015 |
LPO coated NPs | 1496.3 ± 11 | 0.55 ± 0.01 | 703.8 ± 52 | 1.72 ± 0.12 | 374.7 ± 7.8 | 2.4 ± 0.03 | 847.2 ± 14.2 | 1.43 ± 0.1 |
LF | 2282.2 ± 21 | 0.36 ± 0.006 | 636.2 ± 21 | 1.28 ± 0.02 | 1955.6 ± 37 | 0.42 ± 0.003 | 874.7 ± 6.3 | 0.93 ± 0.01 |
LF-loaded NPs | 1285.2 ± 59 | 1.06 ± 0.04 | 510.6 ± 15 | 2.66 ± 0.98 | 269.7 ± 6.2 | 5.03 ± 0.19 | 812.2 ± 4.5 | 1.67 ± 0.06 |
LF coated NPs | 755.1 ± 84 | 3.06 ± 0.11 | 463 ± 29 | 5.0 ± 0.18 | 189.1 ± 7.2 | 12.26 ± 0.44 | 605.2 ± 21.4 | 3.82 ± 0.14 |
LPO + LF | 1980.9 ± 13 | 0.45 ± 0.008 | 545.6 ± 18 | 1.65 ± 0.02 | 1846.6 ± 7.7 | 0.49 ± 0.008 | 730.1 ± 4.4 | 1.23 ± 0.016 |
LPO + LF-loaded NPs | 816.6 ± 42 | 4.02 ± 0.42 | 472.8 ± 15 | 6.94 ± 0.07 | 215.9 ± 3 | 15.21 ± 0.16 | 620.3 ± 17 | 5.3 ± 0.057 |
LPO + LF coated NPs | 1173.9 ± 70 | 0.94 ± 0.05 | 540.5 ± 8 | 2.04 ± 0.1 | 713.6 ± 15.5 | 1.54 ± 0.081 | 811.8 ± 38 | 1.38 ± 0.07 |
LF coated LPO-loaded NPs | 669.2 ± 40 | 3.16 ± 0.02 | 256.9 ± 38 | 8.23 ± 0.05 | 150.1 ± 4.8 | 14.1 ± 0.093 | 539.3 ± 29 | 3.92 ± 0.026 |
LPO coated LF-loaded NPs | 968.4 ± 77 | 1.04 ± 0.11 | 542.7 ± 29 | 1.8 ± 0.02 | 244.7 ± 14 | 4.1 ± 0.26 | 815.5 ± 42 | 1.23 ± 0.07 |
5-FU | 1.09 ± 0.02 | 1.74 ± 0.1 | 1.23 ± 0.05 | 1.53 ± 0.05 | 1.60 ± 0.05 | 1.19 ± 0.12 | 1.46 ± 0.04 | 0.72 ± 0.02 |